Regulation of the expression of inducible nitric oxide synthase

Biological Chemistry

Volumn 384, Issue 10-11, 2003, Pages 1343-1364

  Kleinert, Hartmut ^a   Schwarz, Petra M ^a   Förstermann, Ulrich ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Expression; iNOS; mRNA stability; Promoter; RNA binding proteins; Signal transduction pathways; Transcription factors

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CALYCULIN A; CANTHARIDIN; CLOFIBRATE; CYANOGINOSIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLOSPORIN A; CYTOKINE; ERBSTATIN; GAMMA INTERFERON; GENISTEIN; HERBIMYCIN A; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; ISOENZYME; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PIRINIXIC ACID; PROTEIN TYROSINE KINASE INHIBITOR; RNA BINDING PROTEIN; STAT1 PROTEIN; TACROLIMUS; THREONINE PROTEINASE; TRANSCRIPTION FACTOR; TYRPHOSTIN; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; CELL TYPE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; GENETIC TRANSCRIPTION; HUMAN; MICROBIAL ACTIVITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CYTOKINES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTERFERON-STIMULATED GENE FACTOR 3; LIPOPOLYSACCHARIDES; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

BACTERIA (MICROORGANISMS); JANUS;

EID: 0345547431     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2003.152     Document Type: Review

References (234)

1. Ambs, S., Ogunfusika, M.O., Merriam, W.G., Bennett, W.P., Billiar, T.R., and Harris, C.C. (1998). Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice. Proc. Natl. Acad. Sci. USA 95, 8823-8828.
2. Badger, A.M., Cook, M.N., Lark, M.W., NewmanTarr, T.M., Swift, B.A., Nelson, A.H., Barone, F.C., and Kumar, S. (1998). SB 203580 inhibits p38 mitogen-activated protein kinase, nitric oxide production, and inducible nitric oxide synthase in bovine cartilage-derived chondrocytes. J. Immunol. 161, 467-473.
3. Baek, S.H., Kwon, T.K., Lim, J.H., Lee, Y.J., Chang, H.W., Lee, S.J., Kim, J.H., and Kwun, K.B. (2000). Secretory phospholipase A2-potentiated inducible nitric oxide synthase expression by macrophages requires NF-κB activation. J. Immunol. 164, 6359-6365.
4. Baek, S.H., Lim, J.H., Park, D.W., Kim, S.Y., Lee, Y.H., Kim, J.R., and Kim, J.H. (2001). Group IIA secretory phospholipase A(2) stimulates inducible nitric oxide synthase expression via ERK and NF-κB in macrophages. Eur. J. Immunol. 31, 2709-2717.
5. Baek, S.H., Yun, S.S., Kwon, T.K., Kim, J.R., Chang, H.W., Kwak, J.Y., Kim, J.H., and Kwun, K.B. (1999). The effects of two new antagonists of secretory PLA2 on TNF, iNOS, and COX-2 expression in activated macrophages. Shock 12, 473-478.
6. Beck, K.F., Eberhardt, W., Walpen, S., Apel, M., and Pfeilschifter, J. (1998). Potentiation of nitric oxide synthase expression by superoxide in interleukin-1β-stimulated rat mesangial cells. FEBS Lett. 435, 35-38.
7. Bellamy, R., and Hill, A.V. (1997). A bi-allelic tetranucleotide repeat in the promoter of the human inducible nitric oxide synthase gene. Clin. Genet. 52, 192-193.
8. Bellmann, K., Burkart, V., Bruckhoff, J., Kolb, H., and Landry, J. (2000). p38-dependent enhancement of cytokine-induced nitric-oxide synthase gene expression by heat shock protein 70. J. Biol. Chem. 275, 18172-18179.
9. Bhat, N.R., Feinstein, D.L., Shen, Q., and Bhat, A.N. (2002). p38 MAPK-mediated transcriptional activation of inducible nitric-oxide synthase in glial cells. J. Biol. Chem. 277, 29584-29592.
10. Blair, L.A., Heitmeier, M.R., Scarim, A.L., Maggi, L.B., Jr., and Corbett, J.A. (2001). Double-stranded RNA-dependent protein kinase is not required for double-stranded RNA-induced nitric oxide synthase expression or nuclear factor-κB activation by islets. Diabetes 50, 283-290.
11. Blair, L.A., Maggi, L.B., Jr., Scarim, A.L., and Corbett, J.A. (2002). Role of interferon regulatory factor-1 in double-stranded RNA-induced iNOS expression by mouse islets. J. Biol. Chem. 277, 359-365.
12. Boehm, U., Klamp, T., Groot, M., and Howard, J.C. (1997). Cellular responses to interferon-γ. Annu. Rev. Immunol. 15, 749-795.
13. Bogdan, C. (2001). Nitric oxide and the immune response. Nature Immunol. 2, 907-916.
14. Brennan, C.M., and Steitz, J.A. (2001). HuR and mRNA stability. Cell. Mol. Life Sci. 58, 266-277.
15. Burgner, D., Xu, W., Rockett, K., Gravenor, M., Charles, I.G., Hill, A.V., and Kwiatkowski, D. (1998). Inducible nitric oxide synthase polymorphism and fatal cerebral malaria. Lancet 352, 1193-1194.
16. Caivano, M. (1998). Role of MAP kinase cascades in inducing arginine transporters and nitric oxide synthetase in RAW264 macrophages. FEBS Lett. 429, 249-253.
17. Calzada, J.E., Lopez-Nevot, M.A., Beraun, Y., and Martin, J. (2002). No evidence for association of the inducible nitric oxide synthase promoter polymorphism with Trypanosoma cruzi infection. Tissue Antigens 59, 316-319.
18. Caput, D., Beutler, B., Hartog, K., Thayer, R., Brown-Shimer, S., and Cerami, A. (1986). Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA 83, 1670-1674.
19. Carpenter, L., Cordery, D., and Biden, T.J. (2001). Protein kinase Cδ activation by interleukin-1β stabilizes inducible nitric-oxide synthase mRNA in pancreatic β-cells. J. Biol. Chem. 276, 5368-5374.
20. Castrillo, A., Bodelon, O.G., and Bosca, L. (2000). Inhibitory effect of IGF-I on type 2 nitric oxide synthase expression in Ins-1 cells and protection against activation-dependent apoptosis: involvement of phosphatidylinositol 3-kinase. Diabetes 49, 209-217.
21. Chan, E.D., Winston, B.W., Uh, S.T., Wynes, M.W., Rose, D.M., and Riches, D.W. (1999). Evaluation of the role of mitogen-activated protein kinases in the expression of inducible nitric oxide synthase by IFN-γ and TNF-α in mouse macrophages. J. Immunol. 162, 415-422.
22. Chen, C.C., Wang, J.K., and Lin, S.B. (1998). Antisense oligonucleotides targeting protein kinase C-α, -βI, or -δ but not -E inhibit lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages: involvement of a nuclear factor κB-dependent mechanism. J. Immunol. 161, 6206-6214.
23. Chong, M.M., Thomas, H.E., and Kay, T.W. (2002). Suppressor of cytokine signaling-1 regulates the sensitivity of pancreatic β cells to tumor necrosis factor. J. Biol. Chem. 277, 27945-27952.
24. Chu, S.C., Wu, H.P., Banks, T.C., Eissa, N.T., and Moss, J. (1995). Structural diversity in the 5′-untranslated region of cytokine-stimulated human inducible nitric oxide synthase mRNA. J. Biol. Chem. 270, 10625-10630.
25. Chu, S.C., Marks Konczalik, J., Wu, H.P., Banks, T.C., and Moss, J. (1998). Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters. Biochem. Biophys. Res. Commun. 248, 871-878.
26. Coccia, E.M., Stellacci, E., Marziali, G., Weiss, G., and Battistini, A. (2000). IFN-γ and IL-4 differently regulate inducible NO synthase gene expression through IRF-1 modulation. Int. Immunol. 12, 977-985.
27. Crespo, A., Filla, M.B., and Murphy, W.J. (2002). Low responsiveness to IFN-γ, after pretreatment of mouse macrophages with lipopolysaccharides, develops via diverse regulatory pathways. Eur. J. Immunol. 32, 710-719.
28. Da Silva, J., Pierrat, B., Mary, J.L., and Lesslauer, W. (1997). Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes. J. Biol. Chem. 272, 28373-28380.
29. Darville, M.I., and Eizirik, D.L. (1998). Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells. Diabetologia 41, 1101-1108.
30. de Vera, M.E., Shapiro, R.A., Nüssler, A.K., Mudgett, J.S., Simmons, R.L., Morris, S.M., Jr., Billiar, T.R., and Geller, D.A. (1996a). Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc. Natl. Acad. Sci. USA 93, 1054-1059.
31. de Vera, M.E., Wong, J.M., Zhou, J.Y., Tzeng, E., Wong, H.R., Billiar, T.R., and Geller, D.A. (1996b). Cytokine-induced nitric oxide synthase gene transcription is blocked by the heat shock response in human liver cells. Surgery 120, 144-149.
32. de Vera, M.E., Taylor, B.S., Wang, Q., Shapiro, R.A., Billiar, T.R., and Geller, D.A. (1997). Dexamethasone suppresses iNOS gene expression by upregulating I-κB-α and inhibiting NF-κB. Am. J. Physiol. 273, G1290-G1296.
33. Delgado, M., and Ganea, D. (2000). Inhibition of IFN-γ-induced janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. J. Immunol. 165, 3051-3057.
34. Diaz Guerra, M.J., Bodelon, O.G., Velasco, M., Whelan, R., Parker, P.J., and Bosca, L. (1996). Up-regulation of protein kinase C-epsilon promotes the expression of cytokine-inducible nitric oxide synthase in RAW 264.7 cells. J. Biol. Chem. 271, 32028-32033.
35. Diaz-Guerra, M.J., Castrillo, A., Martin-Sanz, P., and Bosca, L. (1999). Negative regulation by phosphatidylinositol 3-kinase of inducible nitric oxide synthase expression in macrophages. J. Immunol. 162, 6184-6190.
36. Dlaska, M., and Weiss, G. (1999). Central role of transcription factor NF-IL6 for cytokine and iron-mediated regulation of murine inducible nitric oxide synthase expression. J. Immunol. 162, 6171-6177.
37. Doi, M., Shichiri, M., Katsuyama, K., Marumo, F., and Hirata, Y. (2000). Cytokine-activated p42/p44 MAP kinase is involved in inducible nitric oxide synthase gene expression independent from NF-κB activation in vascular smooth muscle cells. Hypertens. Res. 23, 659-667.
38. Doi, M., Shichiri, M., Katsuyama, K., Ishimaru, S., and Hirata, Y. (2002). Cytokine-activated Jak-2 is involved in inducible nitric oxide synthase expression independent from NF-κB activation in vascular smooth muscle cells. Atherosclerosis 160, 123-132.
39. Dong, Z.Y., Yang, X.L., Xie, K.P., Juang, S.H., Llansa, N., and Fidler, I.J. (1995). Activation of inducible nitric oxide synthase gene in murine macrophages requires protein phosphatases 1 and 2A activities. J. Leukoc. Biol. 58, 725-732.
40. Eberhardt, W., Kunz, D., and Pfeilschifter, J. (1994). Pyrrolidine dithiocarbamate differentially affects interleukin-1β- and cAMP-Induced nitric oxide synthase expression in rat renal mesangial cells. Biochem. Biophys. Res. Commun. 200, 163-170.
41. Eberhardt, W., Kunz, D., Hummel, R., and Pfeilschifter, J. (1996). Molecular cloning of the rat inducible nitric oxide synthase gene promoter. Biochem. Biophys. Res. Commun. 223, 752-756.
42. Eberhardt, W., Pluss, C., Hummel, R., and Pfeilschifter, J. (1998). Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-1β and cAMP in rat mesangial cells. J. Immunol. 160, 4961-4969.
43. Eissa, N.T., Yuan, J.W., Haggerty, C.M., Choo, E.K., Palmer, C.D., and Moss, J. (1998). Cloning and characterization of human inducible nitric oxide synthase splice variants: a domain, encoded by exons 8 and 9, is critical for dimerization. Proc. Natl. Acad. Sci. USA 95, 7625-7630.
44. Evans, T., Carpenter, A., and Cohen, J. (1994). Inducible nitric-oxide-synthase mRNA is transiently expressed and destroyed by a cycloheximide-sensitive process. Eur. J. Biochem. 219, 563-569.
45. Fahmi, H., Di Battista, J.A., Pelletier, J.P., Mineau, F., Ranger, P., and Martel-Pelletier, J. (2001). Peroxisome proliferator-activated receptor γ activators inhibit interleukin-1β-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes. Arthritis Rheum. 44, 595-607.
46. Faure, V., Hecquet, C., Courtois, Y., and Goureau, O. (1999). Role of interferon regulatory factor-1 and mitogen-activated protein kinase pathways in the induction of nitric oxide synthase-2 in retinal pigmented epithelial cells. J. Biol. Chem. 274, 4794-4800.
47. Felley-Bosco, E., Bender, F.C., Courjault-Gautier, F., Bron, C., and Quest, A.F. (2000). Caveolin-1 down-regulates inducible nitric oxide synthase via the proteasome pathway in human colon carcinoma cells. Proc. Natl. Acad. Sci. USA 97, 14334-14339.
48. Feng, X., Guo, Z., Nourbakhsh, M., Hauser, H., Ganster, R., Shao, L., and Geller, D.A. (2002). Identification of a negative response element in the human inducible nitric-oxide synthase (hiNOS) promoter: the role of NF-κB-repressing factor (NRF) in basal repression of the hiNOS gene. Proc. Natl. Acad. Sci. USA 15, 15.
49. Finder, J.D., Litz, J.L., Blaskovich, M.A., McGuire, T.F., Qian, Y.M., Hamilton, A.D., Davies, P., and Sebti, S.M. (1997). Inhibition of protein geranylgeranylation causes a superinduction of nitric-oxide synthase-2 by interleukin-1β in vascular smooth muscle cells. J. Biol. Chem. 272, 13484-13488.
50. Finder, J.D., Petrus, J.L., Hamilton, A., Villavicencio, R.T., Pitt, B.R., and Sebti, S.M. (2001). Signal transduction pathways of IL-1β-mediated iNOS in pulmonary vascular smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 281, L816-823.
51. Flodstrom, M., and Eizirik, D.L. (1997). Interferon-γ-induced interferon regulatory factor-1 (IRF-1) expression in rodent and human islet cells precedes nitric oxide production. Endocrinology 138, 2747-2753.
52. Forrester, K., Ambs, S., Lupold, S.E., Kapust, R.B., Spillare, E.A., Weinberg, W.C., Felley Bosco, E., Wang, X.W., Geller, D.A. et al. (1996). Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc. Natl. Acad. Sci. USA 93, 2442-2447.
53. Förstermann, U., Li, H., Schwarz, P.M., and Kleinert, H. (2003). NO synthesis and NOS regulation. In: Signal Transduction by Reactive Oxygen and Nitrogen Species, H.J. Forman, J. Fukuto and M. Torres, eds. (Dordrecht, The Netherlands: Kluwer Academic Publishers), pp. 119-154.
54. Fujimura, M., Tominaga, T., Kato, I., Takasawa, S., Kawase, M., Taniguchi, T., Okamoto, H., and Yoshimoto, T. (1997). Attenuation of nitric oxide synthase induction in IRF-1-deficient glial cells. Brain Res. 759, 247-250.
55. Fukuda, K., Akao, S., Ohno, Y., Yamashita, K., and Fujiwara, H. (2001). Inhibition by costunolide of phorbol ester-induced transcriptional activation of inducible nitric oxide synthase gene in a human monocyte cell line THP-1. Cancer Lett. 164, 7-13.
56. Galea, E., Reis, D.J., and Feinstein, D.L. (1994). Cloning and expression of inducible nitric oxide synthase from rat astrocytes. J. Neurosci. Res. 37, 406-414.
57. Galea, E., Reddi, J., and Feinstein, D.L. (1995). Differential suppression of glial nitric oxide synthase induction by structurally related tyrosine kinase inhibitors. Neurosci. Lett. 200, 195-198.
58. Ganster, R.W., Taylor, B.S., Shao, L., and Geller, D.A. (2001). Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-κB. Proc. Natl. Acad. Sci. USA 98, 8638-8643.
59. Gao, J., Morrison, D.C., Parmely, T.J., Russell, S.W., and Murphy, W.J. (1997). An interferon-γ-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-γ and lipopolysaccharide. J. Biol. Chem. 272, 1226-1230.
60. Gay, R.D., Dawson, S.J., Murphy, W.J., Russell, S.W., and Latchman, D.S. (1998). Activation of the iNOS gene promoter by Brn-3 POU family transcription factors is dependent upon the octamer motif in the promoter. Biochim. Biophys. Acta 1443, 315-322.
61. Geller, D.A., and Billiar, T.R. (1998). Molecular biology of nitric oxide synthases. Cancer Metastasis Rev. 17, 7-23.
62. Geller, D.A., Lowenstein, C.J., Shapiro, R.A., Nussler, A.K., Di Silvio, M., Wang, S.C., Nakayama, D.K., Simmons, R.L., Snyder, S.H., and Billiar, T.R. (1993). Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc. Natl. Acad. Sci. USA 90, 3491-3495.
63. Ghosh, S., May, M.J., and Kopp, E.B. (1998). NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260.
64. Gilbert, R.S., and Herschman, H.R. (1993). 'Macrophage' nitric oxide synthase is a glucocorticoid-inhibitable primary response gene in 3T3 cells. J. Cell Physiol. 157, 128-132.
65. Goldring, C., Reveneau, S., Algarte, M., and Jeannin, J.F. (1996). In vivo footprinting of the mouse inducible nitric oxide synthase gene: inducible protein occupation of numerous sites including oct and NF-IL6. Nucleic Acids Res. 24, 1682-1687.
66. Green, L.C., Tannenbaum, S.R., and Goldmann, P. (1981). Nitrate synthesis in the germfree and conventional rat. Science 212, 56-58.
67. Guan, Z., Buckman, S.Y., Springer, L.D., and Morrison, A.R. (1999). Both p38α(MAPK) and JNK/SAPK pathways are important for induction of nitric-oxide synthase by interleukin-1β in rat glomerular mesangial cells. J. Biol. Chem. 274, 36200-36206.
68. Guo, H., Cai, C.Q., and Kuo, P.C. (2002). Hepatocyte nuclear factor-4α mediates redox sensitivity of inducible nitric-oxide synthase gene transcription. J. Biol. Chem. 277, 5054-5060.
69. Gupta, A.K., Diaz, R.A., Higham, S., and Kone, B.C. (2000). α-MSH inhibits induction of C/EBPβ-DNA binding activity and NOS2 gene transcription in macrophages. Kidney Int. 57, 2239-2248.
70. Ha, H.C., Hester, L.D., and Snyder, S.H. (2002). Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc. Natl. Acad. Sci. USA 99, 3270-3275.
71. Harbrecht, B.G., Taylor, B.S., Xu, Z., Ramalakshmi, S., Ganster, R.W., and Geller, D.A. (2001). cAMP inhibits inducible nitric oxide synthase expression and NF-κB-binding activity in cultured rat hepatocytes. J. Surg. Res. 99, 258-264.
72. Hassa, P.O., Covic, M., Hasan, S., Imhof, R., and Hottiger, M.O. (2001). The enzymatic and DNA binding activity of PARP-1 are not required for NF-κB coactivator function. J. Biol. Chem. 276, 45588-45597.
73. Hatanaka, Y., Fujii, J., Fukutomi, T., Watanabe, T., Che, W., Sanada, Y., Igarashi, Y., and Taniguchi, N. (1998). Reactive oxygen species enhances the induction of inducible nitric oxide synthase by sphingomyelinase in RAW264.7 cells. Biochim. Biophys. Acta 1393, 203-210.
74. Hattori, Y., Nakanishi, N., and Kasai, K. (2002). Statin enhances cytokine-mediated induction of nitric oxide synthesis in vascular smooth muscle cells. Cardiovasc. Res. 54, 649-658.
75. Hausding, M., Witteck, A., Rodriguez-Pascual, F., von Eichel-Streiber, C., Förstermann, U., and Kleinert, H. (2000). Inhibition of small G proteins of the Rho family by statins or Clostridium difficile toxin B enhances cytokine-mediated induction of NO synthase II. Br. J. Pharmacol. 131, 553-561.
76. Heitmeier, M.R., Scarim, A.L., and Corbett, J.A. (1998). Double-stranded RNA-induced inducible nitric-oxide synthase expression and interleukin-1 release by murine macrophages requires NF-κB activation. J. Biol. Chem. 273, 15301-15307.
77. Hibbs, J.B., Taintor, R.R., and Vavrin, Z. (1987). Macrophage cytotoxicity: role of L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 235, 473-476.
78. Hinz, B., Brune, K., and Pahl, A. (2000). Nitric oxide inhibits inducible nitric oxide synthase mRNA expression in RAW 264.7 macrophages. Biochem. Biophys. Res. Commun. 271, 353-357.
79. Hobbs, M.R., Udhayakumar, V., Levesque, M.C., Booth, J., Roberts, J.M., Tkachuk, A.N., Pole, A., Coon, H., Kariuki, S., Nahlen, B.L. et al.(2002). A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children. Lancet 360, 1468-1475.
80. Hsu, Y.W., Chi, K.H., Huang, W.C., and Lin, W.W. (2001). Ceramide inhibits lipopolysaccharide-mediated nitric oxide synthase and cyclooxygenase-2 induction in macrophages: effects on protein kinases and transcription factors. J. Immunol. 166, 5388-5397.
81. Hua, L.L., Zhao, M.L., Cosenza, M., Kim, M.O., Huang, H., Tanowitz, H.B., Brosnan, C.F., and Lee, S.C. (2002). Role of mitogen-activated protein kinases in inducible nitric oxide synthase and TNFα expression in human fetal astrocytes. J. Neuroimmunol. 126, 180-189.
82. Hunter, T. (1995). Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80, 225-236.
83. Ikeda, U., Shimpo, M., Ikeda, M., Minota, S., and Shimada, K. (2001). Lipophilic statins augment inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes. J. Cardiovasc. Pharmacol. 38, 69-77.
84. Inoue, T., Fukuo, K., Nakahashi, T., Hata, S., Morimoto, S., and Ogihara, T. (1995). cGMP upregulates nitric oxide synthase expression in vascular smooth muscle cells. Hypertension 25, 711-714.
85. Iyengar, R., Stuehr, D.J., and Marletta, M.A. (1987). Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst. Proc. Natl. Acad. Sci. USA 84, 6369-6373.
86. Jaiswal, M., LaRusso, N.F., and Gores, G.J. (2001). Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am. J. Physiol. Gastrointest. Liver Physiol. 281, G626-634.
87. Janabi, N. (2002). Selective inhibition of cyclooxygenase-2 expression by 15-deoxy-delta(12,14)(12,14)-prostaglandin J(2) in activated human astrocytes, but not in human brain macrophages. J. Immunol. 168, 4747-4755.
88. Jeon, Y.J., Han, S.H., Lee, Y.W., Yea, S.S., and Yang, K.H. (1998). Inhibition of NF-κB/Rel nuclear translocation by dexamethasone: mechanism for the inhibition of iNOS gene expression. Biochem. Mol. Biol. Int. 45, 435-441.
89. Jijon, H.B., Churchill, T., Malfair, D., Wessler, A., Jewell, L.D., Parsons, H.G., and Madsen, K.L. (2000). Inhibition of poly(ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 279, G641-651.
90. Johannesen, J., Tarnow, L., Parving, H.H., Nerup, J., and Pociot, F. (2000). CCTTT-repeat polymorphism in the human NOS2-promoter confers low risk of diabetic nephropathy in type 1 diabetic patients. Diabetes Care 23, 560-562.
91. Jung, F., Palmer, L.A., Zhou, N., and Johns, R.A. (2000). Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes. Circ. Res. 86, 319-325.
92. Kamijo, R., Harada, H., Matsuyama, T., Bosland, M., Gerecitano, J., Shapiro, D., Le, J., Koh, S.I., Kimura, T., Green, S.J., Mak, T.W., Taniguchi, T., and Vilcek, J. (1994). Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263, 1612-1615.
93. Kanno, K., Hirata, Y., Imai, T., and Marumo, F. (1993). Induction of nitric oxide synthase gene by interleukin in vascular smooth muscle cells. Hypertension 22, 34-39.
94. Karlsen, A.E., Ronn, S.G., Lindberg, K., Johannesen, J., Galsgaard, E.D., Pociot, F., Nielsen, J.H., Mandrup-Poulsen, T., Nerup, J., and Billestrup, N. (2001). Suppressor of cytokine signaling 3 (SOCS-3) protects β-cells against interleukin-1β- and interferon-γ-mediated toxicity. Proc. Natl. Acad. Sci. USA 98, 12191-12196.
95. Katsuyama, K., Shichiri, M., Marumo, F., and Hirata, Y. (1998a). NO inhibits cytokine-induced iNOS expression and NF-κB activation by interfering with phosphorylation and degradation of IκB-α. Arterioscler. Thromb. Vasc. Biol. 18, 1796-1802.
96. Katsuyama, K., Shichiri, M., Marumo, F., and Hirata, Y. (1998b). Role of nuclear factor-κB activation in cytokine-and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells. Endocrinology 139, 4506-4512.
97. Kim, Y.M., Ko, C.B., Park, Y.P., Kim, Y.J., and Paik, S.G. (1999). Octamer motif is required for the NF-κB-mediated induction of the inducible nitric oxide synthase gene expression in RAW 264.7 macrophages. Mol. Cells 9, 99-109.
98. Kinugawa, K., Shimizu, T., Yao, A., Kohmoto, O., Serizawa, T., and Takahashi, T. (1997). Transcriptional regulation of inducible nitric oxide synthase in cultured neonatal rat cardiac myocytes. Circ. Res. 81, 911-921.
99. Kitamura, Y., Takahashi, H., Nomura, Y., and Taniguchi, T. (1996). Possible involvement of Janus kinase Jak2 in interferon-γ induction of nitric oxide synthase in rat glial cells. Eur. J. Pharmacol. 306, 297-306.
100. Kizaki, T., Suzuki, K., Hitomi, Y., Iwabuchi, K., Onoe, K., Haga, S., Ishida, H., Ookawara, T., and Ohno, H. (2001). Negative regulation of LPS-stimulated expression of inducible nitric oxide synthase by AP-1 in macrophage cell line J774A.1. Biochem. Biophys. Res. Commun. 289, 1031-1038.
101. Kleinert, H., Euchenhofer, C., Ihrig Biedert, I., and Förstermann, U. (1996a). Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-κB. Mol. Pharmacol. 49, 15-21.
102. Kleinert, H., Euchenhofer, C., Ihrig-Biedert, I., and Förstermann, U. (1996b). In murine 3T3 fibroblasts, different second messenger pathways resulting in the induction of NO synthase II (iNOS) converge in the activation of transcription factor NF-κB. J. Biol. Chem. 271, 6039-6044.
103. Kleinert, H., Euchenhofer, C., Fritz, G., Ihrig-Biedert, I., and Förstermann, U. (1998a). Involvement of protein kinases in the induction of NO synthase II in human DLD-1 cells. Br. J. Pharmacol. 123, 1716-1722.
104. Kleinert, H., Wallerath, T., Fritz, G., Ihrig-Biedert, I., Rodriguez-Pascual, F., Geller, D.A., and Förstermann, U. (1998b). Cytokine induction of NO Synthase II in human DLD-1 cells: roles of the JAK-STAT, AP-1 and NF-κB-signaling pathways. Br. J. Pharmacol. 125, 193-201.
105. Kleinert, H., Geller, D.A., and Förstermann, U. (1999). Analysis of the molecular mechanism regulating the induction of the human NO synthase II promoter in human A549/8 alveolar carcinoma cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 359, R 37.
106. Kleinert, H., Boissel, J.P., Schwarz, P.M., and Förstermann, U. (2000). Regulation of the expression of nitric oxide synthase isoforms. In: Nitric Oxide: Biology and Pathobiology, L.J. Ignarro, ed. (New York, USA: Academic Press), pp. 105-128.
107. Koide, M., Kawahara, Y., Nakayama, I., Tsuda, T., and Yokoyama, M. (1993). Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells: synergism with the induction elicited by inflammatory cytokines. J. Biol. Chem. 268, 24959-24966.
108. Kolyada, A.Y., and Madias, N.E. (2001). Transcriptional regulation of the human iNOS gene by IL-1β in endothelial cells. Mol. Med. 7, 329-343.
109. Kolyada, A.Y., Savikovsky, N., and Madias, N.E. (1996). Transcriptional regulation of the human iNOS gene in vascular-smooth-muscle cells and macrophages: evidence for tissue specificity. Biochem. Biophys. Res. Commun. 220, 600-605.
110. Kolyada, A.Y., Fedtsov, A., and Madias, N.E. (2001). 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors upregulate inducible NO synthase expression and activity in vascular smooth muscle cells. Hypertension 38, 1024-1029.
111. Kraynack, N.C., Corey, D.A., Elmer, H.L., and Kelley, T.J. (2002). Mechanisms of NOS2 regulation by Rho GTPase signaling in airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 283, L604-611.
112. Kristof, A.S., Marks-Konczalik, J., and Moss, J. (2001). Mitogen-activated protein kinases mediate activator protein-1-dependent human inducible nitric-oxide synthase promoter activation. J. Biol. Chem. 276, 8445-8452.
113. Kun, J.F., Mordmuller, B., Lell, B., Lehman, L.G., Luckner, D., and Kremsner, P.G. (1998). Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet 351, 265-266.
114. Kun, J.F., Mordmuller, B., Perkins, D.J., May, J., Mercereau-Puijalon, O., Alpers, M., Weinberg, J.B., and Kremsner, P.G. (2001). Nitric oxide synthase 2(Lambarene) (G-954C), increased nitric oxide production, and protection against malaria. J. Infect. Dis. 184, 330-336.
115. Kunz, D., Walker, G., Eberhardt, W., Nitsch, D., and Pfeilschifter, J. (1995). Interleukin 1β-induced expression of nitric oxide synthase in rat renal mesangial cells is suppressed by cyclosporin A. Biochem. Biophys. Res. Commun. 216, 438-446.
116. Kunz, D., Walker, G., Eberhardt, W., and Pfeilschifter, J. (1996). Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin-1β-stimulated mesangial cells: evidence for the involvement of transcriptional and posttranscriptional regulation. Proc. Natl. Acad. Sci. USA 93, 255-259.
117. Kuo, P.C., Abe, K.Y., and Schroeder, R.A. (1997a). Oxidative stress increases hepatocyte iNOS gene transcription and promoter activity. Biochem. Biophys. Res. Commun. 234, 289-292.
118. Kuo, P.C., Schroeder, R.A., and Bartlett, S.T. (1997b). Endotoxin-mediated synthesis of nitric oxide is dependent on Gq protein signal transduction. Surgery 122, 394-402.
119. Kuo, P.C., Abe, K., and Schroeder, R.A. (2000). Superoxide enhances interleukin 1β-mediated transcription of the hepatocyte-inducible nitric oxide synthase gene. Gastroenterology 118, 608-618.
120. LaPointe, M.C., and Sitkins, J.R. (1998). Phospholipase A2 metabolites regulate inducible nitric oxide synthase in myocytes. Hypertension 31, 218-224.
121. Lee, B.S., Kim, Y.M., Kang, H.S., Kim, H.M., Pyun, K.H., and Choi, I. (2001). Octamer binding protein-1 is involved in inhibition of inducible nitric oxide synthase expression by exogenous nitric oxide in murine liver cells. J. Biochem. (Tokyo) 129, 77-86.
122. Levesque, M.C., Hobbs, M.R., Anstey, N.M., Vaughn, T.N., Chancellor, J.A., Pole, A., Perkins, D.J., Misukonis, M.A., Chanock, S.J., Granger, D.L., and Weinberg, J.B. (1999). Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, and disease severity in Tanzanian children with malaria. J. Infect. Dis. 180, 1994-2002.
123. Li, M., Pascual, G., and Glass, C.K. (2000). Peroxisome proliferator-activated receptor γ-dependent repression of the inducible nitric oxide synthase gene. Mol. Cell. Biol. 20, 4699-4707.
124. Liang, Y.C., Tsai, S.H., Tsai, D.C., Lin-Shiau, S.Y., and Lin, J.K. (2001). Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-γ by flavonoids in mouse macrophages. FEBS Lett. 496, 12-18.
125. Lin, A.W., Chang, C.C., and McCormick, C.C. (1996). Molecular cloning and expression of an avian macrophage nitric-oxide synthase cDNA and the analysis of the genomic 5′-flanking region. J. Biol. Chem. 271, 11911-11919.
126. Linn, S.C., Morelli, P.J., Edry, I., Cottongim, S.E., Szabo, C., and Salzman, A.L. (1997). Transcriptional regulation of human inducible nitric oxide synthase gene in an intestinal epithelial cell line. Am. J. Physiol. 272, G1499-G1508.
127. Linscheid, P., Schaffner, A., and Schoedon, G. (1998). Modulation of inducible nitric oxide synthase mRNA stability by tetrahydrobiopterin in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 243, 137-141.
128. Llovera, M., Pearson, J.D., Moreno, C., and Riveros-Moreno, V. (2001). Impaired response to interferon-γ in activated macrophages due to tyrosine nitration of STAT1 by endogenous nitric oxide. Br. J. Pharmacol. 132, 419-426.
129. Lowenstein, C.J., Alley, E.W., Raval, P., Snowman, A.M., Snyder, S.H., Russell, S.W., and Murphy, W.J. (1993). Macrophage nitric oxide synthase gene-two upstream regions mediate induction by interferon-γ and lipopolysaccharide. Proc. Natl. Acad. Sci. USA 90, 9730-9734.
130. Lu, X., Lu, P., Xing, R.Y., Sun, Q.Y., Qiu, Z.W., Han, L., Zhou, X.B., and Zheng, X.F. (2002). [A short tandem repeat polymorphism in the inducible nitric oxide synthase gene in Chinese population]. Yi Chuan Xue Bao 29, 290-293.
131. Lüss, H., Li, R.K., Shapiro, R.A., Tzeng, E., McGowan, F.X., Yoneyama, T., Hatakeyama, K., Geller, D.A., Mickle, D.A., Simmons, R.L., and Billiar, T.R. (1997). Dedifferentiated human ventricular cardiac myocytes express inducible nitric oxide synthase mRNA but not protein in response to IL-1, TNF, IFN-γ, and LPS. J. Mol. Cell. Cardiol. 29, 1153-1165.
132. Lyons, C.R., Orloff, G.J., and Cunningham, J.M. (1992). Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J. Biol. Chem. 267, 6370-6374.
133. MacMicking, J., Xie, Q.W., and Nathan, C. (1997). Nitric oxide and macrophage function. Annu. Rev. Immunol. 15, 323-350.
134. Maggi, L.B., Jr., Heitmeier, M.R., Scheuner, D., Kaufman, R.J., Buller, R.M., and Corbett, J.A. (2000). Potential role of PKR in double-stranded RNA-induced macrophage activation. EMBO J. 19, 3630-3638.
135. Marks-Konczalik, J., Chu, S.C., and Moss, J. (1998). Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor-κB-binding sites. J. Biol. Chem. 273, 22201-22208.
136. Marletta, M.A., Yoon, P.S., Iyengar, R., Leaf, C.D., and Wishnok, J.S. (1988). Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 27, 8706-8711.
137. Martin, E., Nathan, C., and Xie, O.W. (1994). Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 180, 977-984.
138. Martin, J., Calzada, J.E., and Nieto, A. (1999). Inducible nitric oxide synthase (NOS2) gene polymorphism and parasitic diseases. Lancet 353, 72.
139. Massa, P.T., and Wu, C. (1998). Increased inducible activation of NF-κB and responsive genes in astrocytes deficient in the protein tyrosine phosphatase SHP-1. J. Interferon Cytokine Res. 18, 499-507.
140. Matteson, D.M., Shen, D.F., and Chan, C.C. (1999). Inhibition of experimental melanin protein-induced uveitis (EMIU) by targeting nitric oxide via phosphatidylcholine-specific phospholipase C. J. Autoimmun. 13, 197-204.
141. Melillo, G., Musso, T., Sica, A., Taylor, L.S., Cox, G.W., and Varesio, L. (1995). A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J. Exp. Med. 182, 1683-1693.
142. Melillo, G., Taylor, L.S., Brooks, A., Cox, G.W., and Varesio, L. (1996). Regulation of inducible nitric oxide synthase expression in IFN-γ-treated murine macrophages cultured under hypoxic conditions. J. Immunol. 157, 2638-2644.
143. Mellott, J.K., Nick, H.S., Waters, M.F., Billiar, T.R., Geller, D.A., and Chesrown, S.E. (2001). Cytokine-induced changes in chromatin structure and in vivo footprints in the inducible NOS promoter. Am. J. Physiol. Lung Cell. Mol. Physiol. 280, L390-399.
144. Meraz, M.A., White, J.M., Sheehan, K.C.F., Bach, E.A., Rodig, S.J., Dighe, A.S., Kaplan, D.H., Riley, J.K., Greenlund, A.C., Campbell, D. et al. (1996). Trageted disruption of the STAT1 gene in mice reveals unexpected physiologic specificity in the JAK-SAT signaling pathway. Cell 84, 431-442.
145. Messmer, U.K., and Brüne, B. (1994). Modulation of inducible nitric oxide synthase in Rinm5F cells. Cell Signal. 6, 17-24.
146. Miller, B.W., Baier, L.D., and Morrison, A.R. (1997). Overexpression of protein kinase Cζ isoform increases cyclooxygenase-2 and inducible nitric oxide synthase. Am. J. Physiol. 273, C130-C136.
147. Misquitta, C.M., Iyer, V.R., Werstiuk, E.S., and Grover, A.K. (2001). The role of 3′-untranslated region (3′-UTR) mediated mRNA stability in cardiovascular pathophysiology. Mol. Cell. Biochem. 224, 53-67.
148. Mitchell, P., and Tollervey, D. (2000). mRNA stability in eukaryotes. Curr. Opin. Genet. Dev. 10, 193-198.
149. Morris, B.J., Glenn, C.L., Wilcken, D.E., and Wang, X.L. (2001). Influence of an inducible nitric oxide synthase promoter variant on clinical variables in patients with coronary artery disease. Clin. Sci. (Lond.) 100, 551-556.
150. Morris, B.J., Markus, A., Glenn, C.L., Adams, D.J., Colagiuri, S., and Wang, L. (2002). Association of a functional inducible nitric oxide synthase promoter variant with complications in type 2 diabetes. J. Mol. Med. 80, 96-104.
151. Muhl, H., and Pfeilschifter, J. (1994). Possible role of protein kinase CE isoenzyme in inhibition of interleukin 1β induction of nitric oxide synthase in rat renal mesangial cells. Biochem. J. 303, 607-612.
152. Muhl, H., and Pfeilschifter, J. (1995). Amplification of nitric oxide synthase expression by nitric oxide in interleukin 1 β-stimulated rat mesangial cells. J. Clin. Invest. 95, 1941-1946.
153. Mukaida, N., Morita, M., Ishikawa, Y., Rice, N., Okamoto, S., Kasahara, T., and Matsushima, K. (1994). Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-κB is target for glucocorticoid-mediated interleukin 8 gene repression. J. Biol. Chem. 269, 13289-13295.
154. Muniyappa, R., Xu, R., Ram, J.L., and Sowers, J.R. (2000). Inhibition of Rho protein stimulates iNOS expression in rat vascular smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 278, H1762-1768.
155. Murphy, W.J., Muroi, M., Zhang, C.X., Suzuki, T., and Russell, S.W. (1996). Both basal and enhancer κB elements are required for full induction of the mouse inducible nitric oxide synthase gene. J. Endotoxin Res. 3, 381-393.
156. Musial, A., and Eissa, N.T. (2001). Inducible nitric-oxide synthase is regulated by the proteasome degradation pathway. J. Biol. Chem. 276, 24268-24273.
157. Nakayama, I., Kawahara, Y., Tsuda, T., Okuda, M., and Yokoyama, M. (1994). Angiotensin-II inhibits cytokine-stimulated inducible nitric oxide synthase expression in vascular smooth muscle cells. J. Biol. Chem. 269, 11628-11633.
158. Nandan, D., Lo, R., and Reiner, N.E. (1999). Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovani. Infect. Immun. 67, 4055-4063.
159. Nishiya, T., Uehara, T., Edamatsu, H., Kaziro, Y., Itoh, H., and Nomura, Y. (1997). Activation of Stat1 and subsequent transcription of inducible nitric oxide synthase gene in C6 glioma cells is independent of interferon-γ-induced MAPK activation that is mediated by p21ras. FEBS Lett. 408, 33-38.
160. Nuedling, S., Karas, R.H., Mendelsohn, M.E., Katzenellenbogen, J.A., Katzenellenbogen, B.S., Meyer, R., Vetter, H., and Grohe, C. (2001). Activation of estrogen receptor β is a prerequisite for estrogen-dependent upregulation of nitric oxide synthases in neonatal rat cardiac myocytes. FEBS Lett. 502, 103-108.
161. Nunokawa, Y., Oikawa, S., and Tanaka, S. (1996). Human inducible nitric oxide synthase gene is transcriptionally regulated by nuclear factor-κB dependent mechanism. Biochem. Biophys. Res. Commun. 223, 347-352.
162. Nunokawa, Y., Oikawa, S., and Tanaka, S. (1997). Expression of human inducible nitric oxide synthase is regulated by both promoter and 3′-regions. Biochem. Biophys. Res. Commun. 233, 523-526.
163. Oliver, F.J., Menissier-de Murcia, J., Nacci, C., Decker, P., Andriantsitohaina, R., Muller, S., de la Rubia, G., Stoclet, J.C., and de Murcia, G. (1999). Resistance to endotoxic shock as a consequence of defective NF-κB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J. 18, 4446-4454.
164. Olivier, M., Romero-Gallo, B.J., Matte, C., Blanchette, J., Posner, B.I., Tremblay, M.J., and Faure, R. (1998). Modulation of interferon-γ-induced macrophage activation by phosphotyrosine phosphatases inhibition. Effect on murine Leishmaniasis progression. J. Biol. Chem. 273, 13944-13949.
165. Pahan, K., Sheikh, F.G., Namboodiri, A.M., and Singh, I. (1997). Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J. Clin. Invest. 100, 2671-2679.
166. Pahan, K., Sheikh, F.G., Khan, M., Namboodiri, A.M., and Singh, I. (1998a). Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes. J. Biol. Chem. 273, 2591-2600.
167. Pahan, K., Sheikh, F.G., Namboodiri, A.M., and Singh, I. (1998b). Inhibitors of protein phosphatase 1 and 2A differentially regulate the expression of inducible nitric-oxide synthase in rat astrocytes and macrophages. J. Biol. Chem. 273, 12219-12226.
168. Pahan, K., Raymond, J.R., and Singh, I. (1999). Inhibition of phosphatidylinositol 3-kinase induces nitric-oxide synthase in lipopolysaccharide-or cytokine-stimulated C6 glial cells. J. Biol. Chem. 274, 7528-7536.
169. Pahan, K., Liu, X., McKinney, M.J., Wood, C., Sheikh, F.G., and Raymond, J.R. (2000). Expression of a dominant-negative mutant of p21(ras) inhibits induction of nitric oxide synthase and activation of nuclear factor-κB in primary astrocytes. J. Neurochem. 74, 2288-2295.
170. Palmer, L.A., Semenza, G.L., Stoler, M.H., and Johns, R.A. (1998). Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. Am. J. Physiol. 274, L212-L219.
171. Paludan, S.R., Ellermann-Eriksen, S., Lovmand, J., and Mogensen, S.C. (1999). Interleukin-4-mediated inhibition of nitric oxide production in interferon-γ-treated and virus-infected macrophages. Scand J. Immunol. 49, 169-176.
172. Pance, A., Chantome, A., Reveneau, S., Bentrari, F., and Jeannin, J.F. (2002). A repressor in the proximal human inducible nitric oxide synthase promoter modulates transcriptional activation. FASEB J. 16, 631-633.
173. Pang, L., and Hoult, J.R. (1997). Repression of inducible nitric oxide synthase and cyclooxygenase-2 by prostaglandin E2 and other cyclic AMP stimulants in J774 macrophages. Biochem. Pharmacol. 53, 493-500.
174. Pellacani, A., Chin, M.T., Wiesel, P., Ibanez, M., Patel, A., Yet, S.F., Hsieh, C.M., Paulauskis, J.D., Reeves, R., Lee, M.E., and Perrella, M.A. (1999). Induction of high mobility group-I(Y) protein by endotoxin and interleukin-1β in vascular smooth muscle cells. Role in activation of inducible nitric oxide synthase. J. Biol. Chem. 274, 1525-1532.
175. Pellacani, A., Wiesel, P., Razavi, S., Vasilj, V., Feinberg, M.W., Chin, M.T., Reeves, R., and Perrella, M.A. (2001). Down-regulation of high mobility group-I(Y) protein contributes to the inhibition of nitric-oxide synthase 2 by transforming growth factor-β1. J. Biol. Chem. 276, 1653-1659.
176. Peng, H.B., Spiecker, M., and Liao, J.K. (1998). Inducible nitric oxide: an autoregulatory feedback inhibitor of vascular inflammation. J. Immunol. 161, 1970-1976.
177. Perez-Sala, D., Cernuda-Morollon, E., Diaz-Cazorla, M., Rodriguez-Pascual, F., and Lamas, S. (2001). Posttranscriptional regulation of human iNOS by the NO/cGMP pathway. Am. J. Physiol. Renal. Physiol. 280, F466-473.
178. Perrella, M.A., Pellacani, A., Wiesel, P., Chin, M.T., Foster, L.C., Ibanez, M., Hsieh, C.M., Reeves, R., Yet, S.F., and Lee, M.E. (1999). High mobility group-I(Y) protein facilitates nuclear factor-κB binding and transactivation of the inducible nitric-oxide synthase promoter/enhancer. J. Biol. Chem. 274, 9045-9052.
179. Rao, K.M. (2000). Molecular mechanisms regulating iNOS expression in various cell types. J. Toxicol. Environ. Health B Crit. Rev. 3, 27-58.
180. Ratovitski, E.A., Alam, M.R., Quick, R.A., McMillan, A., Bao, C., Kozlovsky, C., Hand, T.A., Johnson, R.C., Mains, R.E., Eipper, B.A., and Lowenstein, C.J. (1999a). Kalirin inhibition of inducible nitric-oxide synthase. J. Biol. Chem. 274, 993-999.
181. Ratovitski, E.A., Bao, C., Quick, R.A., McMillan, A., Kozlovsky, C., and Lowenstein, C.J. (1999b). An inducible nitric-oxide synthase (NOS)-associated protein inhibits NOS dimerization and activity. J. Biol. Chem. 274, 30250-30257.
182. Rodriguez-Pascual, F., Hausding, M., Ihrig-Biedert, I., Furneaux, H., Levy, A.P., Förstermann, U., and Kleinert, H. (2000). Complex contribution of the 3′-untranslated region to the expressional regulation of the human inducible nitric-oxide synthase gene. Involvement of the RNA-binding protein HuR. J. Biol. Chem. 275, 26040-26049.
183. Rudders, S., Gaspar, J., Madore, R., Voland, C., Grall, F., Patel, A., Pellacani, A., Perrella, M.A., Libermann, T.A., and Oettgen, P. (2001). ESE-1 is a novel transcriptional mediator of inflammation that interacts with NF-κ B to regulate the inducible nitric-oxide synthase gene. J. Biol. Chem. 276, 3302-3309.
184. Sakitani, K., Nishizawa, M., Inoue, K., Masu, Y., Okumura, T., and Ito, S. (1998). Synergistic regulation of inducible nitric oxide synthase gene by CCAAT/enhancer-binding protein beta and nuclear factor-κB in hepatocytes. Genes Cells 3, 321-330.
185. Saura, M., Zaragoza, C., Diaz-Cazorla, M., Hernandez-Perera, O., Eng, E., Lowenstein, C.J., Perez-Sala, D., and Lamas, S. (1998). Involvement of transcriptional mechanisms in the inhibition of NOS2 expression by dexamethasone in rat mesangial cells. Kidney Int. 53, 38-49.
186. Sawada, T., Falk, L.A., Rao, P., Murphy, W.J., and Pluznik, D.H. (1997). IL-6 induction of protein-DNA complexes via a novel regulatory region of the inducible nitric oxide synthase gene promoter-role of octamer binding proteins. J. Immunol. 158, 5267-5276.
187. Schaffer, M.R., Fuchs, N., Proksch, B., Bongartz, M., Beiter, T., and Becker, H.D. (1998). Tacrolimus impairs wound healing: a possible role of decreased nitric oxide synthesis. Transplantation 65, 813-818.
188. Schindler, C., and Darnell, J.E. (1995). Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64, 621-651.
189. Scholz-Pedretti, K., Eberhardt, W., Rupprecht, G., Beck, K.F., Spitzer, S., Pfeilschifter, J., and Kaszkin, M. (2000). Inhibition of NF-κB-mediated pro-inflammatory gene expression in rat mesangial cells by the enolized 1,3-dioxane-4, 6-dione-5-carboxamide, CGP-43182. Br. J. Pharmacol. 130, 1183-1190.
190. Sekine, N., Fukumoto, S., Ishikawa, T., Okazaki, T., and Fujita, T. (2001). GH inhibits interferon-γ-induced signal transducer and activator of transcription-1 activation and expression of the inducible isoform of nitric oxide synthase in INS-1 cells. Endocrinology 142, 3909-3916.
191. Shiojiri, T., Wada, K., Nakajima, A., Katayama, K., Shibuya, A., Kudo, C., Kadowaki, T., Mayumi, T., Yura, Y., and Kamisaki, Y. (2002). PPARγ ligands inhibit nitrotyrosine formation and inflammatory mediator expressions in adjuvant-induced rheumatoid arthritis mice. Eur. J. Pharmacol. 448, 231-238.
192. Shiraishi, A., Dudler, J., and Lotz, M. (1997). Role of IFN regulatory factor-1 in synovitis and nitric oxide production. J. Immunol. 159, 3549-3554.
193. Singh, K., Balligand, J.L., Fischer, T.A., Smith, T.W., and Kelly, R.A. (1996). Regulation of cytokine-inducible nitric oxide synthase in cardiac myocytes and microvascular endothelial cells. Role of extracellular signal-regulated kinases 1 and 2 (ERK1/ERK2) and STAT1α. J. Biol. Chem. 271, 1111-1117.
194. Sirsjo, A., Gidlof, A.C., Olsson, A., Torma, H., Ares, M., Kleinert, H., Förstermann, U., and Hansson, G.K. (2000). Retinoic acid inhibits nitric oxide synthase-2 expression through the retinoic acid receptor-α. Biochem. Biophys. Res. Commun. 270, 846-851.
195. Soderberg, M., Raffalli-Mathieu, F., and Lang, M.A. (2002). Inflammation modulates the interaction of heterogeneous nuclear ribonucleoprotein (hnRNP) I/polypyrimidine tract binding protein and hnRNP L with the 3′-untranslated region of the murine inducible nitric-oxide synthase mRNA. Mol. Pharmacol. 62, 423-431.
196. Spink, J., and Evans, T. (1997). Binding of the transcription factor interferon regulatory factor-1 to the inducible nitric-oxide synthase promoter. J. Biol. Chem. 272, 24417-24425.
197. Spink, J.M., Cohen, J., and Evans, T. (1995). Delineation of the vsmc iNOS enhancer and its interaction with the trasncription factor, relA. Endothelium 3, S-50.
198. St Denis, A., Chano, F., Tremblay, P., St Pierre, Y., and Descoteaux, A. (1998). Protein kinase C-α modulates lipopolysaccharide-induced functions in a murine macrophage cell line. J. Biol. Chem. 273, 32787-32792.
199. Stuehr, D.J., and Marletta, M.A. (1985). Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. USA 82, 7738-7742.
200. Sun, H., and Tonks, N.K. (1994). The coordinated action of protein tyrosine phosphatases and kinases in cell signaling. Trends Biochem. Sci. 19, 480-485.
201. Takai, Y., Sasaki, T., and Matozaki, T. (2001). Small GTP-binding proteins. Physiol. Rev. 81, 153-208.
202. Taylor, B.S., and Geller, D.A. (2000). Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene. Shock 13, 413-424.
203. Taylor, B.S., Kim, Y.M., Wang, Q., Shapiro, R.A., Billiar, T.R., and Geller, D.A. (1997). Nitric oxide down-regulates hepatocyte-inducible nitric oxide synthase gene expression. Arch. Surg. 132, 1177-1183.
204. Taylor, B.S., de Vera, M.E., Ganster, R.W., Wang, Q., Shapiro, R.A., Morris, S.M., Jr., Billiar, T.R., and Geller, D.A. (1998). Multiple NF-κB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J. Biol. Chem. 273, 15148-15156.
205. Taylor, B.S., Liu, S., Villavicencio, R.T., Ganster, R.W., and Geller, D.A. (1999). The role of protein phosphatases in the expression of inducible nitric oxide synthase in the rat hepatocyte. Hepatology 29, 1199-1207.
206. Teng, X., Zhang, H., Snead, C., and Catravas, J.D. (2000). A reverse nuclear factor-κB element in the rat type II nitric oxide synthase promoter mediates the induction by interleukin-1β and interferon-γ in rat aortic smooth muscle cells. Gen. Pharmacol. 34, 9-16.
207. Teng, X., Li, D., Catravas, J.D., and Johns, R.A. (2002a). C/EBP-β mediates iNOS induction by hypoxia in rat pulmonary microvascular smooth muscle cells. Circ. Res. 90, 125-127.
208. Teng, X., Zhang, H., Snead, C., and Catravas, J.D. (2002b). Molecular mechanisms of iNOS induction by IL-1 β and IFN-γ in rat aortic smooth muscle cells. Am. J. Physiol. Cell Physiol. 282, C144-152.
209. Toell, A., Kroncke, K.D., Kleinert, H., and Carlberg, C. (2002). Orphan nuclear receptor binding site in the human inducible nitric oxide synthase promoter mediates responsiveness to steroid and xenobiotic ligands. J. Cell Biochem. 85, 72-82.
210. Tschaikowsky, K., Meisner, M., Schonhuber, F., and Rugheimer, E. (1994). Induction of nitric oxide synthase activity in phagocytic cells inhibited by tricyclodecan-9-yl-xanthogenate (D609). Br. J. Pharmacol. 113, 664-668.
211. Tschaikowsky, K., Schmidt, J., and Meisner, M. (1998). Modulation of mouse endotoxin shock by inhibition of phosphatidylcholine-specific phospholipase C. J. Pharmacol Exp. Ther. 285, 800-804.
212. Uchimura, K., Nakamuta, M., Enjoji, M., Irie, T., Sugimoto, R., Muta, T., Iwamoto, H., and Nawata, H. (2001). Activation of retinoic X receptor and peroxisome proliferator-activated receptor-γ inhibits nitric oxide and tumor necrosis factor-α production in rat Kupffer cells. Hepatology 33, 91-99.
213. Uetani, K., Der, S.D., Zamanian-Daryoush, M., de La Motte, C., Lieberman, B.Y., Williams, B.R., and Erzurum, S.C. (2000). Central role of double-stranded RNA-activated protein kinase in microbial induction of nitric oxide synthase. J. Immunol. 165, 988-996.
214. Vodovotz, Y., Bogdan, C., Paik, J., Xie, Q.W., and Nathan, C. (1993). Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor-β. J. Exp. Med. 178, 605-613.
215. Wagner, A.H., Schwabe, O., and Hecker, M. (2002). Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ. Br. J. Pharmacol. 136, 143-149.
216. Wang, T., Ward, M., Grabowski, P., and Secombes, C.J. (2001). Molecular cloning, gene organization and expression of rainbow trout (Oncorhynchus mykiss) inducible nitric oxide synthase (iNOS) gene. Biochem. J. 358, 747-755.
217. Warke, V.G., Nambiar, M.P., Krishnan, S., Tenbrock, K., Geller, D.A., Koritschoner, N.P., Atkins, J.L., Farber, D.L., and Tsokos, G.C. (2003). Transcriptional activation of the human inducible nitric-oxide synthase promoter by Kruppel-like factor 6. J. Biol. Chem. 278, 14812-14819.
218. Warpeha, K.M., Xu, W., Liu, L., Charles, I.G., Patterson, C.C., Ah-Fat, F., Harding, S., Hart, P.M., Chakravarthy, U., and Hughes, A.E. (1999). Genotyping and functional analysis of a polymorphic (CCTTT)(n) repeat of NOS2A in diabetic retinopathy. FASEB J. 13, 1825-1832.
219. Weinberg, J.B., Hobbs, M.R., Levesque, M.C., Udhayakumar, V., Roberts, J.M., Kariuki, S., Nahlen, B.L., Mwaikambo, E.D., Lal, A.L., Anstey, N.M., and Granger, D.L. (2002). NOS2 promoter polymorphisms as determinants of NO production and susceptibility to severe malaria in humans. Nitric Oxide 6, 488.
220. Weisz, A., Oguchi, S., Cicatiello, L., and Esumi, H. (1994). Dual mechanism for the control of inducible-type NO synthase gene expression in macrophages during activation by interferon-γ and bacterial lipopolysaccharide-transcriptional and post-transcriptional regulation. J. Biol. Chem. 269, 8324-8333.
221. Weisz, A., Cicatiello, L., and Esumi, H. (1996). Regulation of the mouse inducible-type nitric oxide synthase gene promoter by interferon-γ, bacterial lipopolysaccharide and N-G-monomethyl-L-arginine. Biochem. J. 316, 209-215.
222. Werner, F., Jain, M.K., Feinberg, M.W., Sibinga, N.E., Pellacani, A., Wiesel, P., Chin, M.T., Topper, J.N., Perrella, M.A., and Lee, M.E. (2000). Transforming growth factor-β 1 inhibition of macrophage activation is mediated via Smad3. J. Biol. Chem. 275, 36653-36658.
223. Witteck, A., Yao, Y., Fechir, M., Förstermann, U., and Kleinert, H. (2003). Human iNOS gene expression is regulated by Rho protein-mediated changes in the structure of the actin cytoskeleton. Exp. Cell. Res. 287, 106-115.
224. Xie, Q. (1997). A novel lipopolysaccharide-response element contributes to induction of nitric oxide synthase. J. Biol. Chem. 272, 14867-14872.
225. Xie, Q.W., Whisnant, R., and Nathan, C. (1993). Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon γ and bacterial lipopolysaccharide. J. Exp. Med. 177, 1779-1784.
226. Xie, Q.W., Kashiwabara, Y., and Nathan, C. (1994). Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269, 4705-4708.
227. Xu, W., Liu, L., Emson, P.C., Harrington, C.R., and Charles, I.G. (1997). Evolution of a homopurine-homopyrimidine pentanucleotide repeat sequence upstream of the human inducible nitric oxide synthase gene. Gene 204, 165-170.
228. Xu, W., Humphries, S., Tomita, M., Okuyama, T., Matsuki, M., Burgner, D., Kwiatkowski, D., Liu, L., and Charles, I.G. (2000). Survey of the allelic frequency of a NOS2A promoter microsatellite in human populations: assessment of the NOS2A gene and predisposition to infectious disease. Nitric Oxide 4, 379-383.
229. Yamamoto, K., Ikeda, U., and Shimada, K. (1997). Natriuretic peptides modulate nitric oxide synthesis in cytokine-stimulated cardiac myocytes. J. Mol. Cell. Cardiol. 29, 2375-2382.
230. Yang, M.S., Jou, I., Inn-Oc, H., and Joe, E. (2001). Sphingomyelinase but not ceramide induces nitric oxide synthase expression in rat brain microglia. Neurosci. Lett. 311, 133-136.
231. Yin, J.H., Yang, D.I., Ku, G., and Hsu, C.Y. (2000). iNOS expression inhibits hypoxia-inducible factor-1 activity. Biochem. Biophys. Res. Commun. 279, 30-34.
232. Yu, Z., Zhang, W., and Kone, B.C. (2002). Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor κB. Biochem. J. 11, 97-105.
233. Zeng, C., and Morrison, A.R. (2001). Disruption of the actin cytoskeleton regulates cytokine-induced iNOS expression. Am. J. Physiol. Cell. Physiol. 281, C932-940.
234. Zhang, H., Chen, X., Teng, X., Snead, C., and Catravas, J.D. (1998). Molecular cloning and analysis of the rat inducible nitric oxide synthase gene promoter in aortic smooth muscle cells. Biochem. Pharmacol. 55, 1873-1880.